Day 1 - Monday, 2 December 2019
Meeting category
Date(s)
2 Dec 2019
Location
Riyadh,
Saudi Arabia
Organizer
Gulf HIV Clinical Forum 2019
Related Enduring Materials
Enduring Materials
Session 1: Integrase Inhibitors as part of clinical management of PLWH -
Chairs
Bandar Alamri, MD
East Jeddah General Hospital (EJH), Saudi Arabia
Charles Boucher, MD, PhD
Erasmus Medical Center, the Netherlands
Attributes of INSTIs as a First Line Treatment Option
Two Versus Three Drugs - What are the Data?
Integrase Inhibitor Resistance: Does it Matter?
Optimal Use of INSTIs in KSA
Ghassan Wali, MD, FRCP(C)
King Faisal Specialist Hospital and Research Centre, Jeddah, Kingdom of Saudi Arabia
Session 2: Factors affecting the choice of antiretroviral therapy -
Chairs
Sanjay Bhagani, BSc, FRCP
Royal Free Hospital, London, UK
Ghassan Wali, MD, FRCP(C)
King Faisal Specialist Hospital and Research Centre, Jeddah, Kingdom of Saudi Arabia
Switching ARV Therapy - Clinical and Resistance Considerations
Switching ARV Therapy - Clinical and Pharmacological Considerations
ARV Toxicity and Their Management (Including Weight Gain)
Session 3: Optimal ARV treatment in special populations -
Chairs
Roger Paredes, MD, PhD
Hospital Germans Trias i Pujol, Barcelona, Spain
Abdulla Baradwan
-
Antiretroviral Therapy in Pregnancy: Risks and Benefits
Antiretroviral Therapy in HIV-TB Co-Infected Patients (Not Available)
Mohammad Alhazmi, MD, FACP
King Fahad Central Hospital Jizan, Jizan, Kingdom of Saudi Arabia
Breast Feeding in HIV (No permission to publish vlides or video)
Batool Ali, MD
East Jeddah Hospital, Jeddah, Kingdom of Saudi Arabia
Clinical case (No permission to publish slides or video)
Session 4: ARV treatment options in the near future -
Chairs
Bandar Alamri, MD
East Jeddah Hospital, Jeddah, Kingdom of Saudi Arabia
Charles Boucher, MD, PhD
Erasmus Medical Center, Rotterdam, the Netherlands
Novel Treatment Options - Long Acting Antiretroviral Compounds
Reducing HIV Stigma and Promoting Early Diagnosis
Overview
Welcome
We would like to thank everyone that joined the Gulf HIV Clinical Forum 2019: Integrase Inhibitors. We have experienced excellent questions, discussions and great lectures which contributed into a successful meeting!
We would like to encourage you and your colleagues to plan submitting your upcoming research results to the next edition of the meeting. If you would like to share your suggestions for the next program and further ideas, please get in touch with us by email.
On behalf of the Gulf HIV Clinical Forum Meeting Chairs, we would like to thank GSK/ViiV Healthcare for their unrestricted educational grant. We would also like to thank our meeting and educational partners for their invaluable support of the meeting.
We look forward to welcoming you again at the next Gulf HIV Clinical Forum.
Background
The HIV CLINICAL FORUM is developed as part of a series of interactive programs that provide independent medical education on emerging topics in HIV. The program features International and regions experts in order to provide HIV clinicians and allied healthcare professionals with updates on the latest developments related to HIV management, providing opportunities for sharing of clinical experience and presenting results from ongoing and completed cohorts/research programs.
Program Chairs
Local Chair
Support
Support
Meeting Partner
Educational Partner
Language
Related Programs
